The Enforcement Directorate conducted searches at seven locations linked to Sresan Pharmaceuticals and top Tamil Nadu FDA officials over alleged money laundering related to the Coldrif cough syrup case.
Coldrif, found to contain the toxic chemical diethylene glycol (DEG), has been blamed for the deaths of at least 20 children in Madhya Pradesh and Rajasthan.
Despite poor infrastructure and repeated safety violations, Sresan Pharma continued operations for over a decade under a 2011 TNFDA licence; its owner was arrested last week.